A self-reinforcing protein loop drives liver fat buildup
Fatty liver disease affects hundreds of millions of people worldwide, yet the molecular mechanisms that drive fat accumulation inside liver cells remain incompletely understood. New research identifies a self-sustaining feedback loop that actively promotes fat storage in liver-derived cells.
At its center is a protein called PPARγ, a key regulator of genes involved in fat cell differentiation and lipid storage. The study, published in eLife, shows that another protein, SETD6, binds to PPARγ and chemically modifies it through methylation (the addition of a methyl group at a specific site). That modification is not neutral: it then causes PPARγ to activate the gene that produces SETD6 itself.
A loop that sustains itself
The result is a positive feedback loop: more SETD6 leads to more methylated PPARγ, which drives more SETD6 production. Using RNA sequencing, a technique that measures which genes are active, the researchers found that both proteins are required for the full activation of lipid metabolism genes. In liver-derived cells, this translated into the formation of fat droplets.
The work was done in cell lines in the laboratory, not in patients. The findings are therefore preliminary. Still, the authors argue that the SETD6-PPARγ axis represents a potential new therapeutic target for metabolic dysfunction-associated fatty liver disease (MAFLD) and obesity.
Why this matters for aging
Fatty liver is not only a metabolic condition. It raises the risk of liver cirrhosis, liver cancer, and cardiovascular disease, all of which increase with age. Fat accumulation in the liver is also linked to insulin resistance, a mechanism that accelerates cellular aging. If this feedback loop turns out to be as central as these results suggest, disrupting it could eventually offer a way to slow liver fat accumulation. Clinical applications remain a long way off.
Want to research this yourself?
Search for example:
- PPARγ methylation fatty liver
- SETD6 lipid metabolism
- metabolic dysfunction associated liver disease